Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons.
about
Neuroprotective and symptomatic effects of targeting group III mGlu receptors in neurodegenerative diseaseAge-related changes in glial cells of dopamine midbrain subregions in rhesus monkeysSelective neuronal vulnerability to oxidative stress in the brain.Glial cell line-derived neurotrophic factor protects midbrain dopaminergic neurons against lipopolysaccharide neurotoxicity.Lithium ameliorates lipopolysaccharide-induced microglial activation via inhibition of toll-like receptor 4 expression by activating the PI3K/Akt/FoxO1 pathway.Glucocorticoid receptors in the retina, Müller glia and the formation of Müller glia-derived progenitors.Inflammation as a causative factor in the aetiology of Parkinson's diseaseParaquat induces epigenetic changes by promoting histone acetylation in cell culture models of dopaminergic degeneration.Cytotoxicity of paraquat in microglial cells: Involvement of PKCdelta- and ERK1/2-dependent NADPH oxidaseViscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS)Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic interventionMicroglial responses to dopamine in a cell culture model of Parkinson's disease.Peripheral leukocyte apoptosis in patients with Parkinsonism: correlation with clinical characteristics and neuroimaging findingsPeripheral inflammation increases the damage in animal models of nigrostriatal dopaminergic neurodegeneration: possible implication in Parkinson's disease incidence.Primary phagocytosis of neurons by inflamed microglia: potential roles in neurodegenerationParkinson's disease and periodontitis - the missing link? A review.Short-term effects of an endotoxin on substantia nigra dopamine neurons.Melatonin As A Therapeutic Resource For Inflammatory Visual Diseases.Lymphocytes reduce nigrostriatal deficits in the 6-hydroxydopamine mouse model of Parkinson's disease.Simvastatin prevents the inflammatory process and the dopaminergic degeneration induced by the intranigral injection of lipopolysaccharide.Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease.Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2-antioxidant signaling pathways.Nitric oxide-producing microglia mediate thrombin-induced degeneration of dopaminergic neurons in rat midbrain slice culture.Suppression of Brain Mast Cells Degranulation Inhibits Microglial Activation and Central Nervous System Inflammation.Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson's disease.
P2860
Q26995351-61F51D9A-6FCA-4C77-9218-EAF8BAB36F0BQ33859902-73B7659A-C123-4B50-8993-D82E61632520Q33868370-44E9D9FB-ED1A-4CB8-9DEF-A5505345A6F9Q34077007-BCD9C708-6D6A-412B-A26A-CE59D6A21DD3Q34108882-A6A646A0-42D4-4C97-9E06-50448377F9C4Q34348716-9A590C0D-414D-4BBE-896F-5B95779D2FE8Q36052641-40B4E4AD-1C4C-4DDE-9372-B2604550E6F3Q36123405-3D60E867-3096-48FB-A049-5814875ADF50Q36156588-9DD45603-F400-455F-90D4-10B090122539Q36546334-1580657F-D1A3-430B-B368-D0CF0F7FAEC3Q36919403-DF3E0A71-A5AF-451C-9AD4-2E61EB88603DQ37389383-DC8EA9C5-32C6-4234-83FA-60F0F042180EQ37699935-5DF9D2BA-5B1C-4392-A391-C9ABCABE0267Q37878282-32C3A1E5-AC0D-44B7-83A5-E3DB9291D0B0Q37992053-199111C4-A47A-4CA4-81D7-75E22360A122Q38349197-2EFB3997-E830-422E-8712-69BA403574B2Q38565248-DE38993E-BE11-4353-8080-E4352C2E9A7CQ39089092-020BB398-08A8-4DDE-860E-15AAAE733AD4Q40625594-2FD9BB42-FAFC-4715-80DC-B2CA83B0E8F0Q46875236-70E4C6E7-1DD4-4B4B-AA22-5F2189F1C958Q48109363-75E2B007-A68B-4C72-B67B-064EFCBCCC50Q48290344-EBD10824-6DCE-46EE-8688-B342D704BE0AQ48568146-E77F0CCB-2EA6-44A9-AC47-C7AA0572557EQ48956990-94A8164D-3F32-438F-9A24-C4C75D74237EQ55230759-E23632B8-EDA5-4FEE-B87E-3C008E66AEDD
P2860
Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Inflammatory process as a dete ...... ia nigra dopaminergic neurons.
@ast
Inflammatory process as a dete ...... ia nigra dopaminergic neurons.
@en
type
label
Inflammatory process as a dete ...... ia nigra dopaminergic neurons.
@ast
Inflammatory process as a dete ...... ia nigra dopaminergic neurons.
@en
prefLabel
Inflammatory process as a dete ...... ia nigra dopaminergic neurons.
@ast
Inflammatory process as a dete ...... ia nigra dopaminergic neurons.
@en
P2093
P1476
Inflammatory process as a dete ...... tia nigra dopaminergic neurons
@en
P2093
J L Venero
M Tomás-Camardiel
P2888
P304
P356
10.1007/S00702-004-0121-3
P577
2004-03-19T00:00:00Z